Complex Variant t(9;22) Chromosome Translocations in Five Cases of Chronic Myeloid Leukemia

Table 1

Clinical characteristic of the patients. M: male, F: female, WBC: white blood cell count, PLT: platelet count, BM: bone marrow, Eo: eosinophils, Bso: basophils, HU: hydroxyurea, IFN𝜶: interferon 𝜶, Auto: autologus, PBSC: peripheral blood stem cell transplantation.

Case	Sex/Age	WBC (10^9/L)	PLT (10^9/L)	BM Blasts (%)	BM Eo/Bso (%)	Phase at diagnosis	Treatment	Follow-up (months)
(a)	M/75	306	390	0	6/1	Chronic	HU, imatinib	30
(b)	F/50	671	408	2	11/2	Chronic	HU, imatinib	+12
(c)	F/59	123	250	0	—	Chronic	HU, imatinib	+18
(d)	M/56	431	222	0	5/0	Chronic	HU, auto-PBSC, IFN𝛼, imatinib	+71
(e)	F/71	689	479	2	5/2	Chronic	HU, imatinib	+86